On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a "patient" of a 340B program covered entity eligible to receive a 340B drug.
On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a patient of a 340B program covered entity eligible to receive a 340B drug. In Genesis.
On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a “patient” of a 340B program covered entity eligible to receive a 340B drug..